Prognostic Factors in Diffuse Large Bcell Lymphoma Treated by Riskadopted Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Factors in Diffuse Large Bcell Lymphoma Treated by Riskadopted Therapy

Published:2006 Issue:5 Volume:45 Page:247-252
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tomita Naoto¹,Kodama Fumio²,Motomura Shigeki²,Koharazawa Hideyuki³,Fujita Hiroyuki⁴,Harano Hiroshi⁵,Kanamori Heiwa¹,Ishigatsubo Yoshiaki¹

Affiliation:

1. Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine

2. Department of Chemotherapy, Kanagawa Cancer Center

3. Department of Hematology, Fujieda Municipal General Hospital

4. Department of Hematology, Shizuoka Red Cross Hospital

5. Department of Hematology, Yokohama City University Medical Center

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/45/5/45_5_247/_pdf

Reference20 articles.

1. 1. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced nonHodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993.

2. 2. A predictive model for aggressive nonHodgkin's lymphoma. the International NonHodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994, 1993.

3. 3. Pettengell R, Radford JA, Morgenstern GR et al. Survival benefit from highdose therapy with autologous blood progenitorcell transplantation in poorprognosis nonHodgkin lymphoma. J Clin Oncol 14: 586-592, 1996.

4. 4. Haioun C, Lepage E, Gisselbrecht C et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poorrisk aggressive nonHodgkin's lymphoma: updated results of the prospective study LNH872. J Clin Oncol 15: 1131-1137, 1997.

5. 5. Gianni AM, Bregni M, Siena S et al. Highdose chemotherapyand autologous bone marrow transplantation compared with MACOPB in aggressive Bcell lymphoma. N Engl J Med 336: 1290-1297, 1997.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of K-ras Mutation and C-myc Overexpression on the Prognosis of Diffuse Large B-Cell Lymphomas;UHOD-ULUSLAR HEMATOL;2022

2. Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma;BMC Cancer;2020-05-18

3. Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for ‘unfit’ patients classified by comprehensive geriatric assessment;European Journal of Haematology;2015-07-06

4. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study;Leukemia;2014-08-25

5. Correlation of Nm23 and P27 Expression in Nodal Diffuse Large B Cell Lymphomas with Clinicopathologic Parameters and the Effect on Prognosis;Erciyes Tıp Dergisi/Erciyes Medical Journal;2014-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3